MPL PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MPL PHARMA
Largest movements
- Cash -€232,697
down €232,697 (-50.0%), from €465,291 to €232,594
mainly Contributions, distributions and other (-€204,000) and Current investments (-€150,000)
- Current investments +€150,000
new in 2025: €150,000
- Intangible fixed assets -€22,189
down €22,189 (-17.4%), from €127,588 to €105,399
- Other debts +€154,541
up €154,541 (+400.9%), from €38,550 to €193,091
- Debts after one year -€146,067
down €146,067 (-63.1%), from €231,598 to €85,531
of which Other amounts payable: -€100,000
- Reserves -€91,000
down €91,000 (-21.2%), from €430,000 to €339,000
of which Distributable reserves: -€91,000
- Accrued charges and deferred income -€15,350
down €15,350 (-97.5%), from €15,750 to €400
- Gross operating margin +€7,798
up €7,798 (+2.3%), from €332,485 to €340,284
- Taxes +€5,369
up €5,369 (+10.6%), from €50,471 to €55,839
- Depreciation +€4,940
up €4,940 (+6.2%), from €79,140 to €84,080
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,279,148 | €1,183,729 | -€95,419 | -7.5% |
| Fixed assets | 21/28 | €661,042 | €645,193 | -€15,849 | -2.4% |
| Intangible fixed assets | 21 | €127,588 | €105,399 | -€22,189 | -17.4% |
| Tangible fixed assets | 22/27 | €533,454 | €539,794 | +€6,340 | +1.2% |
| Land and buildings | 22 | €482,959 | €498,832 | +€15,873 | +3.3% |
| Plant, machinery and equipment | 23 | €16,528 | €15,631 | -€896 | -5.4% |
| Furniture and vehicles | 24 | €33,968 | €25,331 | -€8,637 | -25.4% |
| Current assets | 29/58 | €618,105 | €538,536 | -€79,569 | -12.9% |
| Stocks and contracts in progress | 3 | €74,337 | €78,738 | +€4,400 | +5.9% |
| Stocks | 30/36 | €74,337 | €78,738 | +€4,400 | +5.9% |
| Amounts receivable within one year | 40/41 | €78,477 | €74,823 | -€3,654 | -4.7% |
| Trade receivables | 40 | €70,132 | €74,823 | +€4,691 | +6.7% |
| Other amounts receivable | 41 | €8,345 | - | -€8,345 | |
| Current investments | 50/53 | - | €150,000 | +€150,000 | |
| Cash at bank and in hand | 54/58 | €465,291 | €232,594 | -€232,697 | -50.0% |
| Deferred charges and accrued income | 490/1 | - | €2,381 | +€2,381 | |
| Total equity and liabilities | 10/49 | €1,279,148 | €1,183,729 | -€95,419 | -7.5% |
| Equity | 10/15 | €814,771 | €724,196 | -€90,575 | -11.1% |
| Contributions | 10/11 | €220,000 | €220,000 | = | 0.0% |
| Reserves | 13 | €430,000 | €339,000 | -€91,000 | -21.2% |
| Tax-exempt reserves | 132 | €15,000 | €15,000 | = | 0.0% |
| Distributable reserves | 133 | €415,000 | €324,000 | -€91,000 | -21.9% |
| Profit (loss) carried forward | 14 | €164,771 | €165,196 | +€425 | +0.3% |
| Amounts payable | 17/49 | €464,377 | €459,534 | -€4,843 | -1.0% |
| Amounts payable after more than one year | 17 | €231,598 | €85,531 | -€146,067 | -63.1% |
| Financial debts | 170/4 | €131,598 | €85,531 | -€46,067 | -35.0% |
| Other amounts payable | 178/9 | €100,000 | - | -€100,000 | |
| Amounts payable within one year | 42/48 | €217,028 | €373,602 | +€156,574 | +72.1% |
| Current portion of amounts payable after more than one year | 42 | €45,658 | €46,067 | +€409 | +0.9% |
| Trade debts | 44 | €97,952 | €98,293 | +€341 | +0.3% |
| Suppliers | 440/4 | €97,952 | €98,293 | +€341 | +0.3% |
| Taxes, remuneration and social security | 45 | €34,868 | €36,151 | +€1,283 | +3.7% |
| Taxes | 450/3 | €17,636 | €18,222 | +€586 | +3.3% |
| Remuneration and social security | 454/9 | €17,232 | €17,929 | +€697 | +4.0% |
| Other amounts payable | 47/48 | €38,550 | €193,091 | +€154,541 | +400.9% |
| Accrued charges and deferred income | 492/3 | €15,750 | €400 | -€15,350 | -97.5% |
| Non-recurring operating income | 76A | €11,781 | - | -€11,781 | |
| Remuneration, social security and pensions | 62 | €87,262 | €84,443 | -€2,820 | -3.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €79,140 | €84,080 | +€4,940 | +6.2% |
| Other operating charges | 640/8 | €3,868 | €2,986 | -€881 | -22.8% |
| Non-recurring operating charges | 66A | €8,166 | - | -€8,166 | |
| Gross operating margin | 9900 | €332,485 | €340,284 | +€7,798 | +2.3% |
| Operating profit (loss) | 9901 | €154,050 | €168,774 | +€14,725 | +9.6% |
| Financial income | 75/76B | €1,779 | €3,151 | +€1,372 | +77.1% |
| Recurring financial income | 75 | €1,779 | €3,151 | +€1,372 | +77.1% |
| Financial charges | 65/66B | €4,238 | €2,662 | -€1,577 | -37.2% |
| Recurring financial charges | 65 | €4,238 | €2,662 | -€1,577 | -37.2% |
| Profit (loss) for the period before taxes | 9903 | €151,591 | €169,264 | +€17,673 | +11.7% |
| Income taxes | 67/77 | €50,471 | €55,839 | +€5,369 | +10.6% |
| Profit (loss) for the period | 9904 | €101,120 | €113,425 | +€12,305 | +12.2% |
| Profit (loss) for the period to be appropriated | 9905 | €101,120 | €113,425 | +€12,305 | +12.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.